The recognition underscores a period of significant expansion for the cannabis enterprise. Beyond revenue gains, the company reported a 161% increase in Adjusted EBITDA during the same three-year window. Raj Grover, founder and CEO of High Tide, credited the consistent performance to the disciplined scaling of the Canna Cabana retail chain, which now operates 232 locations across Canada.
Looking toward future performance, the company is trending toward an $800 million annualized revenue run rate. Operations are also diversifying internationally, with the German pharmaceutical subsidiary Remexian Pharma GmbH emerging as a core growth driver. Having established a foothold in the German medical cannabis market, the firm intends to leverage its existing infrastructure to maintain momentum in both domestic and European sectors.
Comments (0)
No comments yet. Be the first!